Publicaciones

Regulación y Promoción para el uso adecuado de antibioticos en México.Propuesta de lineamientos para la acción

 medicamentos
   

Wirtz V., Taxis K., Dreser A. (2008). Pharmacy customers´ knowledge of side effects of purchased medicines in Mexico. Tropical Medicine & International Health 14, 93-100

 publi_1
   

Gonzales R., Corbett KK., Wirtz V. and Dreser A. (2008). "Quality improvement interventions for resistant infections in developing countries. A shrinking window of opportunity". BMJ 336 (7650): 948-9

 publi_2
   

Wirtz V., Reich MR., Leyva-Flores R. and Dreser A. (2008) "Medicines in Mexico, 1990-2004: Review of research on use, access and quality". Salud Pública Méx 50, S470-479.

 publi_3
   

Dreser A., Wirtz V., Corbett KK., Echániz G. (2008) "Uso de antibióticos en México: los problemas y las políticas". Salud Pública Méx 50. S480-487.

 publi_3
 

Wirtz V., Leyva R., Dreser A., Ángeles A., Reich M. (2005). "Observaciones sobre la propuesta de la nueva política de medicamentos en México". Boletín Fármacos 8 (5). En: Boletín Fármacos

 

Leyva-Flores R, Kageyama M de la L, Eriviti-Erice J. How people respond to illness in Mexico: self-care or medical care. Health Policy 2001; 57: 15-26.

 

Leyva-F. R, Bronfman-P M, Erviti-E. J. Simulated clients in drugstores: Prescriptive behaviour of drugstore attendants. Journal of Social and Administrative Pharmacy 2000; 17: 151-158.

 

Leyva-Flores R, Eriviti-Erice J, Kageyama-Escobar M de la L, Arredondo A. [Medical prescription, drug access and drug expenditure among health service users in Mexico.] Salud Pública de México 1998; 40: 24-31.

 

Leyva-F R, Eriviti-E. J, Ramsey JM, Gasman N. Medical drug utilization pattern for febrile patients in rural areas of Mexico. Journal of Epidemiology 1997; 50: 329-335

   

Garza-Ramos U., R. Morfin-Otero, H.S. Sader, R. N. Jones, E. Hernández, E. Rodriguez-Noriega, A. Sanchez, B. Carrillo, S.Esparza-Ahumada, and J. Silva-Sanchez. 2008. Metallo-b-Lactamase Gene, blaIMP-15, in a Class 1 Integron (In95) from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico. Antimicrob. Agents Chemother. 52:2943-2946.

 publi_5
   
Garza-Ramos U., J. Silva-Sanchez, G. Dávila, V. González, C. Alpuche-Aranda, D. Alcantar-Curiel, V. Richardson-Lopez-Collada, and O. Newton. 2008. The bla-SHV-5 gene is encoded in a compound transposon duplicated in tandem (CTDT) in Enterobacter cloacae. Clin, Microbiol. Infec. Aceptado septiembre 2008
 publi_6
 

L.E. Espinosa de los Monteros, J. Silva-Sanchez, L. V. Jiménez, T. Rojas, U. Garza-Ramos, and V. Valverde. 2008. Outbreak of infection by Extended-Spectrum ß-lactamase SHV-5 Producing Serratia marcescens in a Mexican hospital. J. of Chemother. 20(5):65-71.

   

Cattoir V., P. Nordmann, J. Silva-Sanchez, P. Espinal, and L. Poirel. 2008. ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli. Antimicrob. Agent and Chemother. 52:2929-2932.

 publi_5
   

J.L. Mosqueda-Gómez, A. Montaño-Loza, A.L. Rolón, C. Cervantes, J. M. Bobadilla-del-Valle, J. Silva-Sanchez, U. Garza-Ramos, A. Villasís-Keever, A. Galindo-Fraga, G. M. Ruiz-Palacios, A. Ponce-de-León, and J. Sifuentes-Osornio.2008. Molecular Epidemiology and Risk Factors of Bloodstream Infections Caused by Extended-Spectrum ß-Lactamase Producer Klebsiella pneumoniae. A Case-Control Study. Inter. J. Infec. Dis. (In press. 2008).

 publi_8
 

Garza-Ramos U., R. Morfin-Otero,H.S. Sader, P. Tinoco, E. Rodriguez-Noriega, -lactamasebG. Leon-Garnica, R.N. Jones, and J. Silva-Sanchez. 2008. Metallo- IMP-18 Is Located in Class 1 Integron (In96) in a clinical isolate of P. aeruginosa from Mexico. Int. J. Antimicrob. Agents. 31:78-80.

 

M.E. Velazquez-Meza, M. Aires de Sousa, G. Echániz-Aviles, F. Solórzano-Santos, G. Miranda-Novales, J. Silva-Sánchez, and H. de Lencastre. Surveillance of Methicillin-Resistant Staphylococcus aureus in a Pediatric Hospital in Mexico City during a 7-Year Period (1997 to 2003): Clonal Evolution and Impact of Infection Control. J Clin Microb, Aug. 2004; 42 (8): 3877-3880. ISSN 0095-1137

 

Maria Elena Velazquez-Meza, Surgimiento y diseminación de Staphylococcus aureus meticilinorresistente. Salud Pública de México, Septiembre-octubre 2005; 47 (5): 381-387.

 

G. Echaniz-Aviles, M.E. Velazquez-Meza, M. Aires-de-Sousa, R. Morfín-Otero, E. Rodríguez-Noriega, N. Carnalla Barajas, S. Esparza-Ahumada and H. de Lencastre. Molecular characterization of a dominant methicillin-resistant Staphylococcus aureus (MRSA) clone in a Mexican hospital (1999-2003). European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect, Febrero 2006; 12: 12-28.

 

M.E. Velazquez-Meza1, M. Aires de Sousa2,G. Echaniz-Aviles1, J. Silva-Sanchez1, H. Gonzalez-Marquez3, R.M Hinojosa-Robles4, R. Vazquez-Larios5, Herminia de Lencastre* and Study Groupδ Dissemination of International Clones of Methicillin-Resistant Staphylococcus aureus in hospitals in Mexico. En preparación 2007.

   

Echániz AG, Solórzano SF. Meeting the challenge: Prevention of pneumococcal disease with conjugate vaccines. Salud Pub Mex 2001;43:352-367.

 publi_3
   

DiFabio JL, Castañeda E, Agudelo CI, De la Hoz F, Hortal M, Camou T, Echaniz AG, Carnalla BMN, Heitman I, Hormazabal JC, Brandileone MC, Simonsen V, Regueira M, Corso A, Lovgren M, Talbot JA, De Quadros C and the PAHO Sireva-Vigía Study Group. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigia Group. 1993-1999. Pediatr Infect Dis J. 2001;20:959-67.

 publi_10
   

Hortal M, Lovgren M, de la Hoz F, Agudelo CI, Brandileone MC, Camou T, Casagrande S, Castaneda E, Corso A, Echaniz G, Hormazabal JC, Pace J, Palacio R, Perez-Giffoni G, Ruvinsky R, Di Fabio JL; PAHO SIREVA-Vigia Study Group. Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries: 1993-1999 surveillance. Microb Drug Resist 2001; 7:391-401.

 publi_11
 

Sepúlveda AJ, Valdespino GJL, García GML, Bennett J, Islas RR, Echaniz AG, Fernández de Castro J. A randomized trail demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children. Vaccine 2002; 20:2790-2795.

 

Bennett JV, Fernández de Castro J, Valdespino GJL, García GML, Islas RR, Echaniz AG, Jiménez CA, Sepúlveda AJ. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trial in Mexican schoolchildren. Bulletin of the WHO 2002; 80: 806-812.

 

Gamboa L, Camou T, Hortal M, Castañeda E and the Sireva-Vigía Working Group. Disemination of Streptococcus pneumoniae clone Colombia5 – 19 in Latin America. J Clin Microbiol; 2002; 40:3942-3950

 

Velázquez MME, Aires de Sousa M, Echániz AG, Solórzano SF, Miranda NG, Silva SJ, de Lencastre H. Surveillance of MRSA in a pediatric hospital in Mexico City during a seven-year period (1997-2003): clonal evolution and impact of infection control. J Clin Microb 2004: 42:3877-3880

 

Solórzano SF, Ortiz OLA, Miranda NG, Echániz AG, Soto NA, Guiscafré GH. Serotipos prevalentes de Streptococcus pneumoniae colonizadores de nasofaringe en niños del Distrito Federal. Salud Pub Mex, 2005: 47:276-281.

 

Zemlickova H, Crisóstomo MI, Brandileone MC, Camou T, Castañeda E, Corso A, Echániz-Aviles G, Pasztor M, Tomasz A: Serotypes and clonal types of penicillin-susceptible Streptococcus pneumoniae causing invasive disease in children in five Latin-American countries. Microb Drug Resist 2005;11:195-204

 

Echániz AG, Velázquez MME, Aires de Sousa M, Morfín OR, Rodríguez-Noriega E, Carnalla BN, Esparza AS, de Lencastre H. Molecular characterization of dominant methicillin-resistant Staphylococcus aureus (MRSA) clone in a Mexican hospital (1999 -2003). Clin Microbiol Infect, 2006:12:22-28

 

Lin J, Kaltoft MS, Brandao A, Echániz Aviles G, Brandileone MC, Hollinsgshead SK, Benjamin WH, Nahm MH. Validation of a multiplex pneumococcal serotyping assay with clinical samples. J Clin Microbiol 2006; 44:383-388

 

García S, Levine OS, Cherian T, Gabastou JM, Andrus J and the Working Group members. Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction. Rev Panam Salud Publica/Pan Am J Public Health 2006; 19:340-348

 

Lovgren M, Talbot JA, Brandileone MC, Casagrande ST, Agudelo CI, Castañeda E, Regueira M, Corso A, Heitmann I, Maldonado A, Echániz AG, Soto NA, Hortal M, Camou T, Gabastou JM, DiFabio JL and the Sireva Study Group. Evolution of and international external quality assurance model on Streptococcus pneumoniae in Latin America: The Sireva Project 1993-2005. J Clin Microb 2007; 45:3184-3190.